High Court Won't Review $5B Vioxx Deal
By Abigail Rubenstein ( February 22, 2011, 4:16 PM EST) -- The U.S. Supreme Court declined Tuesday to hear a challenge to Merck & Co. Inc.'s $4.85 billion resolution of the multidistrict litigation over painkiller Vioxx brought by plaintiffs who claimed the mass settlement stripped them of their rights....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.